WallStreetZenWallStreetZen

NASDAQ: ATRI
Atrion Corp Stock

$325.87-1.12 (-0.34%)
Updated Dec 8, 2023
ATRI Price
$325.87
Fair Value Price
$328.46
Market Cap
$573.48M
52 Week Low
$274.98
52 Week High
$705.74
P/E
26.98x
P/B
2.39x
P/S
4.31x
PEG
N/A
Dividend Yield
2.67%
Revenue
$168.60M
Earnings
$21.31M
Gross Margin
38.1%
Operating Margin
14.25%
Profit Margin
12.6%
Debt to Equity
0.1
Operating Cash Flow
$9M
Beta
0.58
Next Earnings
N/A
Ex-Dividend
Nov 30, 2023
Next Dividend
Dec 15, 2023

ATRI Overview

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Zen Score

Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATRI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATRI ($325.87) is undervalued by 0.79% relative to our estimate of its Fair Value price of $328.46 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ATRI ($325.87) is not significantly undervalued (0.79%) relative to our estimate of its Fair Value price of $328.46 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ATRI was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more ATRI due diligence checks available for Premium users.

Be the first to know about important ATRI news, forecast changes, insider trades & much more!

ATRI News

Valuation

ATRI fair value

Fair Value of ATRI stock based on Discounted Cash Flow (DCF)
Price
$325.87
Fair Value
$328.46
Undervalued by
0.79%
ATRI ($325.87) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ATRI ($325.87) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ATRI was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATRI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
26.98x
Industry
45.69x
Market
31.32x
ATRI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ATRI is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

ATRI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.39x
Industry
3.25x
ATRI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATRI's financial health

Profit margin

Revenue
$41.9M
Net Income
$2.9M
Profit Margin
7%
ATRI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ATRI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$264.8M
Liabilities
$24.6M
Debt to equity
0.1
ATRI's short-term assets ($115.74M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATRI's short-term assets ($115.74M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATRI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ATRI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$5.4M
Investing
-$1.8M
Financing
-$3.2M
ATRI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ATRI vs Medical Stocks

TickerMarket Cap1d %P/EP/B
ATRI$573.48M-0.34%26.98x2.39x
BLFS$583.86M+4.25%-5.53x1.76x
OSUR$521.74M+3.05%10.76x1.29x
PLSE$521.32M+1.72%-10.65x10.00x
SMTI$303.63M+0.88%-35.56x6.85x

Atrion Stock FAQ

What is Atrion's quote symbol?

(NASDAQ: ATRI) Atrion trades on the NASDAQ under the ticker symbol ATRI. Atrion stock quotes can also be displayed as NASDAQ: ATRI.

If you're new to stock investing, here's how to buy Atrion stock.

What is the 52 week high and low for Atrion (NASDAQ: ATRI)?

(NASDAQ: ATRI) Atrion's 52-week high was $705.74, and its 52-week low was $274.98. It is currently -53.83% from its 52-week high and 18.51% from its 52-week low.

How much is Atrion stock worth today?

(NASDAQ: ATRI) Atrion currently has 1,759,836 outstanding shares. With Atrion stock trading at $325.87 per share, the total value of Atrion stock (market capitalization) is $573.48M.

Atrion stock was originally listed at a price of $13.88 in Dec 31, 1997. If you had invested in Atrion stock at $13.88, your return over the last 25 years would have been 2,247.77%, for an annualized return of 13.46% (not including any dividends or dividend reinvestments).

How much is Atrion's stock price per share?

(NASDAQ: ATRI) Atrion stock price per share is $325.87 today (as of Dec 8, 2023).

What is Atrion's Market Cap?

(NASDAQ: ATRI) Atrion's market cap is $573.48M, as of Dec 10, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Atrion's market cap is calculated by multiplying ATRI's current stock price of $325.87 by ATRI's total outstanding shares of 1,759,836.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.